Is MRD ready for prime time in multiple myeloma?
Pediatric News ,
On the other hand, Paul Richardson, MD, of Dana-Farber Cancer Institute in Boston, Massachusetts, took the clinicians…
On the other hand, Paul Richardson, MD, of Dana-Farber Cancer Institute in Boston, Massachusetts, took the clinicians…
Last month, the Oncologic Drugs Advisory Committee (ODAC) for the US Food and Drug Administration (FDA) voted in favour of…
Advertisement The ASCO Post is pleased to present Hematology Expert Review, an ongoing feature that quizzes readers on issues…